• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Guaranteed Paid Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Opioid Justice Team: Purdue's Bankruptcy Plan Offers "Easy Pay" Option for OxyContin Users at the Expense of Babies Born Addicted to Opioids

Opioid Justice Team is comprised of attorneys fighting for children born dependent on opioids.

Attorneys representing Purdue's adult victims stand to receive many times the total amount of money that over 6,000 babies and children expect to receive from the $7 billion bankruptcy

Experts say cash windfalls for adult victims can lead to relapse instead of recovery

Babies born to mothers struggling with opioid addiction due to painkillers resulting in Neonatal Abstinence Syndrome (NAS) will face lifelong challenges and require substantial long-term aid

The funds allotted to NAS babies in today's Chapter 11 plan WILL NOT be enough to help these innocent victims to live healthy lives


News provided by

Opioid Justice Team

Mar 16, 2021, 13:55 ET

Share this article

Share this article


NEW YORK, March 16, 2021 /PRNewswire/ -- OxyContin-maker Purdue Pharma filed today its Chapter 11 bankruptcy plan and disclosure statement before U.S. Bankruptcy Judge Robert Drain in New York. As anticipated, the funds allotted for the innocent infants and children swept up in the national opioid epidemic fell far short of ensuring that they receive critical health care, support, and monitoring during their early years.

Purdue's bankruptcy plan allots $750 million to certain victim classes seeking damages for Purdue's history of opioid sales, including babies and children born suffering from opioid dependency adult victims, and other parties.

Under the current plan, said to be valued at over $7 billion, in part funded by money from Sackler family members who are heirs to the Purdue fortune, almost none of the infants and children born dependent on opioids will be eligible for any payment at all. Of the few who make it through the claims process, an overwhelming majority will get no more than $3,500 from which attorney fees, expert costs, Medicaid lien resolution, and minor settlement costs will be deducted. Meanwhile, adult victims may receive significantly more.

Opioids were once prescribed freely to pregnant women. As of 2010, nearly one in three pregnant women in the United States were prescribed opioid painkillers. Many babies born to these mothers are at high risk of being themselves dependent upon opioids, experiencing severe withdrawals, and at risk of developing long-term effects of NAS.  Between 2010 and 2017, the prevalence of babies born with NAS rose by 82.5 percent, increasing in all but two states. Tragically, an opioid-dependent baby is born in the United States every 15 minutes, and these infants and children will face lifelong physical, behavioral, and emotional health challenges.

Attorneys for the babies and children suffering from NAS and its long-term effects will have 21 days to file papers opposing the plan and argue that they deserve substantially more support.

"The proposed Purdue plan fails the most innocent of victims in the opioid crisis – babies and children whose mothers consumed opioids while they were in the womb. It wasn't their choice to be born dependent on drugs and yet their interests have been consistently brushed aside and forgotten in the venues where they are seeking relief, including in this bankruptcy," said Stephen New of West Virginia-based New, Taylor & Associates. "But we haven't forgotten them, and we will plan to strenuously oppose this Purdue plan and demonstrate that the babies deserve a far greater share of the victims' fund."

Unfortunately, mothers with opioid use disorder – and even those who were prescribed opioids like OxyContin while pregnant but took the medication responsibly – face the worst stigma of any population impacted by the opioid epidemic. The stigma surrounding these women keeps mothers from filing personal injury claims on behalf of their children because they fear punishment – including that their child may be taken away from them. That fear prevents these children from receiving the funds they need to live healthy lives.  

The thousands of children born opioid dependent have been documented to suffer from long-term motor problems, such as problems with bones, muscles, and movement, in addition to developmental delays, such as reaching developmental milestones like walking, sitting, talking, and other activities of daily life. They may also experience learning or behavior challenges, speech and language problems, vision problems, trouble sleeping, and other potential struggles. 

In many cases, grandparents become the guardians of babies born to those suffering from opioid addiction who would otherwise end up in foster care. According to congressional estimates, in 2019, 2.5 million grandparents became primary caregivers of their grandchildren due to the opioid epidemic.  Grandparents, often living on fixed incomes, suddenly find themselves responsible for children suffering from a constellation of medical and emotional conditions. These families are in dire financial situations, and a $3,500 gross settlement per child before expenses will effectively do nothing to help these families.

"Infants of the opioid crisis are not similarly situated to government entities and other victims who have different and far less complicated legal remedies. There is no 'quick fix' for NAS and the long-term effects that being born dependent on opioids can cause," said Scott Bickford of New Orleans-based Martzell, Bickford & Centola, a lead attorney for attorneys seeking to protect the children's interests. "We are only beginning to understand the impact of NAS and the resources children need to live healthy lives and even survive infancy. This will require decades of care – evaluation, treatment, and monitoring – costing much more than what Purdue has set aside for them in their plan. It will cost billions, and we will make the case for that in the next several weeks."

A major share of the victims' fund will be allocated to adult victims, including those in recovery, an approach that experts consider dangerous and unwise because it will provide a direct infusion of cash that could worsen their addiction disease, cause relapse, or even lead to deaths.

"We believe that all parties who can show harm due to Purdue's actions have the right to receive relief," Bickford said. "However, the infants and children swept up in this epidemic deserve and need much more than what Purdue is offering to have a chance at survival and to live healthy lives. We will not settle for this, and our fight continues."

Find out about these issues here: http://opioidjusticeteam.com/opioid-infants/

About the Opioid Justice Team
The Opioid Justice Team (OJT) is a group of attorneys working with doctors and national and local nongovernmental organizations fighting to end our nation's opioid epidemic. The OJT seeks not only compensation for damages for their clients but also a comprehensive settlement that will address the root causes of the opioid crisis. For more information, please visit http://opioidjusticeteam.com/.

MEDIA CONTACT:
Caroline Beckmann – Trident DMG
[email protected]
202-440-1783

SOURCE Opioid Justice Team

Related Links

http://opioidjusticeteam.com

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2023 Cision US Inc.